Abstract
Recent evidence suggests that a small subset of cells within tumors have ‘stem cell-like’ characteristics. However, direct proof of the population of liver CSCs remains elusive. Further research is needed to identify cells with stem cell properties in established HCC cell lines. Our previous investigation found that tumor spheres are essentially enriched in CSCs. We hypothesized that chemoresistance in hepatocellular carcinoma (HCC) is due to enrichment of cancer stem cells via the PI3K/Akt pathway. We found that tumor spheres cells formed from HCC cells contained a high percentage of CD90+ cells, and these cells were more tumorigenic and resistant to doxorubicin (DOX), showing a higher proliferation rate and lower apoptosis rate compared to cells in monolayer culture. Treatment with DOX and PI3K/Akt inhibitor increased apoptosis and reduced viability among cells in the tumorspheres. The expression of p-Akt1 was upregulated in tumorsphere-forming cells treated with DOX but downregulated upon further treatment with the PI3K/Akt inhibitor. Our results demonstrate that HCC cells in tumorspheres with cancer stem cell properties achieve chemoresistance via the PI3K/Akt1 pathway.
Keywords: Akt pathway, cancer stem cells, chemoresistance, HCC, tumorsphere.
Anti-Cancer Agents in Medicinal Chemistry
Title:Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway
Volume: 15 Issue: 6
Author(s): Xiao-Li Zhang, Qian Jia, Lin Lv, Tao Deng and Jian Gao
Affiliation:
Keywords: Akt pathway, cancer stem cells, chemoresistance, HCC, tumorsphere.
Abstract: Recent evidence suggests that a small subset of cells within tumors have ‘stem cell-like’ characteristics. However, direct proof of the population of liver CSCs remains elusive. Further research is needed to identify cells with stem cell properties in established HCC cell lines. Our previous investigation found that tumor spheres are essentially enriched in CSCs. We hypothesized that chemoresistance in hepatocellular carcinoma (HCC) is due to enrichment of cancer stem cells via the PI3K/Akt pathway. We found that tumor spheres cells formed from HCC cells contained a high percentage of CD90+ cells, and these cells were more tumorigenic and resistant to doxorubicin (DOX), showing a higher proliferation rate and lower apoptosis rate compared to cells in monolayer culture. Treatment with DOX and PI3K/Akt inhibitor increased apoptosis and reduced viability among cells in the tumorspheres. The expression of p-Akt1 was upregulated in tumorsphere-forming cells treated with DOX but downregulated upon further treatment with the PI3K/Akt inhibitor. Our results demonstrate that HCC cells in tumorspheres with cancer stem cell properties achieve chemoresistance via the PI3K/Akt1 pathway.
Export Options
About this article
Cite this article as:
Zhang Xiao-Li, Jia Qian, Lv Lin, Deng Tao and Gao Jian, Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway, Anti-Cancer Agents in Medicinal Chemistry 2015; 15 (6) . https://dx.doi.org/10.2174/1871520615666150202111721
DOI https://dx.doi.org/10.2174/1871520615666150202111721 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
Current Medicinal Chemistry - Central Nervous System Agents The Recent Progresses on The Improved Therapy of Melanoma by Novel Drug Delivery Systems
Current Drug Targets Role of Unani Medicines in Cancer Control and Management
Current Drug Therapy Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
Current Medicinal Chemistry Gene Sets of Gene Ontology are More Stable Diagnostic Biomarkers than Genes in Oral Squamous Cell Carcinoma
Current Bioinformatics New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase Inhibitors
Recent Patents on CNS Drug Discovery (Discontinued) Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics Understanding Autophagy in Cell Death Control
Current Pharmaceutical Design Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer
Current Topics in Medicinal Chemistry Hepatocellular Carcinoma: Important Biomarkers and their Significance in Molecular Diagnostics and Therapy
Current Medicinal Chemistry GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?
Current Topics in Medicinal Chemistry Safety of Multi-Targeted Kinase Inhibitors as Monotherapy Treatment of Cancer: A Systematic Review of the Literature
Current Drug Safety COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Metal-N-Heterocyclic Carbene Complexes as Anti-Tumor Agents
Current Medicinal Chemistry Serotonin and Cancer: What Is the Link?
Current Molecular Medicine Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Current Molecular Pharmacology The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target
Current Cancer Drug Targets Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Cellular Photodynamic Toxicity of Hematoporphyrin in Various Nanocarrier Systems
Current Nanoscience